Nuwellis, Inc., was incorporated in Delaware on August 22, 2002. The Company commenced operations in November 1999 through Sunshine Heart, Inc. Pte Ltd., and is currently a wholly-owned subsidiary of Sunshine Heart, Inc. Pte Ltd., in Australia. Nuwellis a medical technology company dedicated to improving the lives of patients with fluid overload through science, collaboration and innovative technologies. Nuwellis is committed to advancing the development of heart and kidney care by providing patients with earlier, safer and more controllable fluid management. The Company focuses on the development, production and sale of medical devices for ultrafiltration therapy, including the Aquadex FlexFlow and Aquadex SmartFlow systems (collectively, the "Aquadex Systems ").
